nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Antibody-drug conjugates: integrated bioanalytical and biodisposition assessments in lead optimization and selection
|
Beaumont, Maribel |
|
2018 |
4 |
1 |
p. 1-17 |
artikel |
2 |
ANVISA: an introduction to a new regulatory agency with many challenges
|
Huynh-Ba, Kim |
|
2018 |
4 |
1 |
p. 1-6 |
artikel |
3 |
A randomized, open-label study assessing the bioequivalence of two formulations of Fingolimod 0.5 mg in healthy subjects
|
Tanguay, Mario |
|
2018 |
4 |
1 |
p. 1-6 |
artikel |
4 |
Assessment of clinical immunogenicity of inotuzumab ozogamicin in patients with non-Hodgkin lymphoma and acute lymphoblastic leukemia
|
Jani, Darshana |
|
2018 |
4 |
1 |
p. 1-14 |
artikel |
5 |
Developing key performance indicators to measure the progress of regional regulatory convergence and cooperation in Asia-Pacific Economic Cooperation (APEC)
|
Chong, Sannie Siaw Foong |
|
2018 |
4 |
1 |
p. 1-8 |
artikel |
6 |
Improving the safety of disposable auto-injection devices: a systematic review of use errors
|
Weinhold, Thomas |
|
2018 |
4 |
1 |
p. 1-14 |
artikel |
7 |
Nano-formulations composed of cell membrane-specific cellular lipid extracts derived from target cells: physicochemical characterization and in vitro evaluation using cellular models of breast carcinoma
|
Alharbi, Hanan M. |
|
2018 |
4 |
1 |
p. 1-9 |
artikel |
8 |
Stability challenges not addressed by harmonized guidance – AAPS workshop of the stability focus group, April 3rd- 4th, 2017 in Rockville, MD
|
Khan, Mohd M. |
|
2018 |
4 |
1 |
p. 1-7 |
artikel |
9 |
The journey to AAPS 2020: a reflection from strategic planning to PharmSci 360
|
Polli, Joseph W. |
|
2018 |
4 |
1 |
p. 1-4 |
artikel |